ELEISON RECENT NEWS May 6, 2014 - Mr. Timothy Whitten Joins Eleison Pharmaceuticals Board of Directors January 3, 2014 - Eleison Announces Achievement of Enrollment Milestone in its Phase II Trial of ILC for Pediatric Bone Cancer October 8, 2013 - ILC Granted Orphan Drug Designation in Europe for the Treatment of Osteosarcoma SITEMAP RESOURCES Eleison Pharmaceuticals, LLC. Osteosarcoma Clinical Trials Slideshow Osteosarcoma Clinical Trials Video About Eleison Pharmaceuticals Company News Career Opportunities Contact